Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Tricyclic antidepressants, for example,
amitriptyline (Elavil, Endep), and
monoamine oxidase inhibitors
(MAOIs), for example, tranylcypromine, should not be
combined with albuterol sulfate because of their additive effects on the
vascular system (increased blood pressure, heart rate, etc.). A period of two
weeks should elapse between treatment with albuterol sulphate and tricyclic
antidepressants or monoamine oxidase inhibitors.
Use of albuterol sulphate with other stimulant medications is discouraged
because of their combined effects on heart rate, blood pressure, and the
potential for causing
chest pain in patients with underlying coronary heart
Beta-blockers, for example,
propranolol (Inderal, Inderal LA), block the
effect of albuterol sulphate and may induce bronchospasm in asthmatics.
Albuterol sulphate may cause
hypokalemia (low potassium). Therefore,
combining albuterol sulphate with loop diuretics, for example,
(Lasix) may increase the likelihood of hypokalemia.
PREGNANCY AND BREASTFEEDING SAFETY:
Albuterol sulphate inhalation solution is used for treating children.
are no adequate studies of albuterol sulphate use during pregnancy. Some reports
indicate that albuterol sulphate may cause
congenital defects when used during
It's not known whether albuterol sulphate is excreted in breast milk.